JPS5943476B2 - Method for producing cephalosporin derivatives - Google Patents
Method for producing cephalosporin derivativesInfo
- Publication number
- JPS5943476B2 JPS5943476B2 JP49135292A JP13529274A JPS5943476B2 JP S5943476 B2 JPS5943476 B2 JP S5943476B2 JP 49135292 A JP49135292 A JP 49135292A JP 13529274 A JP13529274 A JP 13529274A JP S5943476 B2 JPS5943476 B2 JP S5943476B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- general formula
- formulas
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Cephalosporin Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
【発明の詳細な説明】
本発明の特徴は6−メトキシペニシリン誘導体を環拡大
して7ーメトキシセフアロスポリンへ導く際、特定の触
媒および溶媒を選定したことにある。DETAILED DESCRIPTION OF THE INVENTION A feature of the present invention lies in the selection of a specific catalyst and solvent when ring-expanding a 6-methoxypenicillin derivative to lead to 7-methoxycephalosporin.
本発明は一般式
(式中、R1はフエニルアセチル基またはチエニルアセ
チル基を、R2は水素原子、アセトキシ基またはカルバ
モイルオキシ基を、R3,R4およびR5は同一または
異なつて水素原子、フエニル基またはトリハロゲノメチ
ル基をそれぞれ意味する。The present invention relates to the general formula (wherein R1 represents a phenylacetyl group or a thienylacetyl group, R2 represents a hydrogen atom, an acetoxy group or a carbamoyloxy group, and R3, R4 and R5 are the same or different and are a hydrogen atom, a phenyl group or Each means a trihalogenomethyl group.
)で表わされるペニシリン誘導体を触媒の存在下、溶媒
中で加熱することによる一般式(式中、R,,R2,R
3,R4およびR,liま前掲と同じものを意味する。) by heating a penicillin derivative represented by the general formula (wherein R,,R2,R
3, R4 and R, li have the same meanings as above.
)で表わされるセフアロスポリン誘導体の製法において
、触媒として一般式(式中、Rは低級アルキル基を、Y
は水素原子またはハロゲン原子を、nは1〜7の整数を
意味する。) In the method for producing a cephalosporin derivative represented by the general formula (wherein R represents a lower alkyl group, Y
represents a hydrogen atom or a halogen atom, and n represents an integer of 1 to 7.
)で表わされるリン化合物を用いることを特徴とする方
法および、前記環拡大反応において、触媒として一般式
〔〕で表わされるリン化合物を用い、溶媒として、沸点
100℃以上の有機ハロゲン化合物を用いることを特徴
とする方法に関する。), and in the ring expansion reaction, a phosphorus compound represented by the general formula [] is used as a catalyst, and an organic halogen compound having a boiling point of 100°C or higher is used as a solvent. Relating to a method characterized by:
こ\において、一般式〔〕で表わされるリン化合物は環
拡大反応の触媒として作用し、その具体的な例としては
、ジエチルメチルホスホネート〔CH3PO(0C2H
5)2〕、ジメチル−n−ブチルホスホネート〔C4H
9PO(0CH3)2〕、ジエチル−nブチルホスホネ
ート〔C4H,PO(0C2H5)2〕、ジエチル−n
−ペンチルホスホネート〔C5HllPO(0C2H5
)2〕、ジエチル−n−ヘキシルホスホネート〔C6H
l3PO(0C2H,)2〕、ジエチル−2−クロルエ
チルホスホネート〔ClCH2CH2PO(0C2H,
)2〕等が挙げられる。In this case, the phosphorus compound represented by the general formula [] acts as a catalyst for the ring expansion reaction, and a specific example thereof is diethylmethylphosphonate [CH3PO(0C2H
5)2], dimethyl-n-butylphosphonate [C4H
9PO(0CH3)2], diethyl-n butylphosphonate [C4H, PO(0C2H5)2], diethyl-n
-pentylphosphonate [C5HllPO(0C2H5
)2], diethyl-n-hexylphosphonate [C6H
13PO(0C2H,)2], diethyl-2-chloroethylphosphonate [ClCH2CH2PO(0C2H,
)2] etc.
近年、セフアロスポリンの新しい誘導体として注目され
つ\ある7ーメトキシセフアロスポリン系抗生物質の製
法として、6位にメトキシ基が導入されたペニシリン誘
導体を環拡大して、7ーメトキシセフアロスポリン誘導
体に導く方法として、酸の存在下、ジオキサン中で環拡
大する方法(特開昭48−10094号)および塩触媒
に属するリン酸二ピリジン塩の存在下、ジオキサン中で
環拡大する方法(米国化学会誌 95巻2401頁 1
973年)がすでに知られている。特開昭48−100
94号に開示された方法は18時間もの長きにわたつて
加熱する必要があり、また酸に対して非常に感受性があ
るとされている6−メトキシペニシリン誘導体に酸触媒
を用いることが有用な方法とは云い難い。In recent years, as a method for producing 7-methoxycephalosporin antibiotics, which have been attracting attention as a new derivative of cephalosporin, a penicillin derivative with a methoxy group introduced at the 6-position is ring-expanded to form a 7-methoxycephalosporin derivative. The methods of deriving the ring expansion include a method of ring expansion in dioxane in the presence of an acid (Japanese Patent Application Laid-open No. 10094/1983) and a method of ring expansion in dioxane in the presence of dipyridine phosphate, which belongs to the salt catalyst (Journal of the American Chemical Society). Volume 95, page 2401 1
973) is already known. Japanese Patent Publication No. 48-100
The method disclosed in No. 94 requires heating for as long as 18 hours, and it is a useful method to use an acid catalyst for the 6-methoxypenicillin derivative, which is said to be very sensitive to acids. It's hard to say.
また、米国化学会誌 95巻 2401頁(1973年
)に開示されている方法は本発明者らが追試した結果、
環拡大反応を完結するには拾数時間以上の加熱を必要と
することがわかつた。In addition, the method disclosed in Journal of the American Chemical Society, Vol. 95, p. 2401 (1973) was repeated by the present inventors, and as a result,
It was found that heating for several hours or more was required to complete the ring expansion reaction.
そこで、本発明者らは公知方法で用いる酸触媒あるいは
塩触媒のいずれにも属さない一般式〔〕で表わされる中
性触媒を選択することにより、6−メトキシペニシリン
誘導体から7ーメトキシセフアロスポリン誘導体への環
拡大反応が好収率で短時間に行なえ、更にはこの触媒と
ある特定の溶媒を組み合せ用いることにより飛躍的に反
応が進雑されると云う知見を得、本発明を完成した。本
発明方法を実施するには、一般式〔1〕で表わされるペ
ニシリン誘導体を溶媒に溶解し、これに一般式〔〕で表
わされる触媒を加えて、80〜170℃好ましくは12
0〜150℃で、数分ないし数時間加熱すればよい。更
に好適な実施形態としては、1,1,2,2−テトラク
ロルエタン(沸点146℃)の如きハロゲン化アルキル
、ブロムベンゼン(沸点156℃)、ジクロルベンゼン
(沸点173〜180℃)、クロルトルエン(沸点15
8〜161℃)の如きハロゲン化アリール等の沸点10
『C以上の有機ハロゲン化合物を溶媒として用いるのが
よい。Therefore, the present inventors selected a neutral catalyst represented by the general formula [ ] that does not belong to either acid catalysts or salt catalysts used in known methods, and thereby converted 7-methoxycephalosporin from 6-methoxypenicillin derivatives. The present invention was completed based on the knowledge that ring expansion reactions to derivatives can be carried out in good yields and in a short time, and that the reaction can be dramatically slowed down by using a combination of this catalyst and a specific solvent. . To carry out the method of the present invention, a penicillin derivative represented by general formula [1] is dissolved in a solvent, a catalyst represented by general formula [] is added thereto, and the temperature is 80 to 170°C, preferably 120°C.
It may be heated at 0 to 150°C for several minutes to several hours. Further preferred embodiments include alkyl halides such as 1,1,2,2-tetrachloroethane (boiling point 146°C), bromobenzene (boiling point 156°C), dichlorobenzene (boiling point 173-180°C), chlorobenzene (boiling point 173-180°C), Toluene (boiling point 15
Boiling point 10 of aryl halide such as 8-161℃)
``It is preferable to use an organic halogen compound of C or higher as a solvent.
反応後必要に応じ、エステル部分を加水分解してカルボ
ン酸に導くことも、更にはカルボン酸の塩とすることも
できる。以下、実施例および参考例を挙げて、本発明を
更に具体的に説明する。After the reaction, if necessary, the ester moiety can be hydrolyzed to lead to a carboxylic acid, or even a salt of a carboxylic acid. Hereinafter, the present invention will be explained in more detail with reference to Examples and Reference Examples.
実施例 1
6α−メI・キシ一6β−フエニルアセトアミド一2,
2−ジメチルペナム一3−カルボン酸トリクロルエチル
エステル−1−オキサイド(500m9)を次表記載の
各溶媒(10m0に溶解し、それぞれの溶液にジエチル
−n−ヘキシルホスホネート(250m7)を加え14
5℃で加熱する。Example 1 6α-meI-xy-6β-phenylacetamide-2,
2-Dimethylpenam-3-carboxylic acid trichloroethyl ester-1-oxide (500m9) was dissolved in each solvent (10m0) listed in the following table, and diethyl-n-hexylphosphonate (250m7) was added to each solution.
Heat at 5°C.
加熱開)始一定時間後の各反応混液をシリカゲルのシー
トにスポツトし、ベンゼン(3)と酢酸エチル(1)の
混液で展開し、各時間における残存原料および目的物の
スポツトの割合をみることにより環拡大反応の進行状況
を観察し、次の結果を得た。前表のように、沸点100
℃以上の有機ハロゲン化合物を溶媒として用いる場合に
は、反応開始後30分で目的物のスポツトは大きく、原
料のスポツトはそれに比し非常に小さくなり、1時間後
には原料のスポツトは完全に消失し、環拡大反応は完結
した。After a certain period of time from the start of heating, each reaction mixture was spotted on a silica gel sheet, developed with a mixed solution of benzene (3) and ethyl acetate (1), and the proportion of spots of the remaining raw material and target product at each time was observed. The progress of the ring expansion reaction was observed using the following methods, and the following results were obtained. As shown in the previous table, boiling point 100
When an organic halogen compound with a temperature of ℃ or higher is used as a solvent, the spot of the target product becomes large 30 minutes after the start of the reaction, the spot of the raw material becomes very small in comparison, and the spot of the raw material completely disappears after 1 hour. However, the ring expansion reaction was completed.
その他の溶媒は反応開始後2時間でも目的物のスポツト
は微弱であつた。実施例 2
7α−メトキシー7β−フエニルアセトアミド3−メチ
ル−3−セフエム一4−カルボン酸トリクロルエチルエ
ステルの製法。With the other solvents, even 2 hours after the start of the reaction, the spots of the target product were weak. Example 2 Method for producing 7α-methoxy7β-phenylacetamide 3-methyl-3-cephem-4-carboxylic acid trichloroethyl ester.
6α−メトキシ−6β−フエニルアセトアミド2,2−
ジメチルペナム一3−カルボン酸トリクロルエチルエス
テル−1−オキサイド(1.09)を1,1,2,2−
テトラクロルエタン(20m1)に溶かし、ジエチル−
n−ヘキシルホスホネート(0.59)を加え、145
℃で1.5時間加熱する。6α-methoxy-6β-phenylacetamide 2,2-
Dimethylpenam-3-carboxylic acid trichloroethyl ester-1-oxide (1.09) was converted into 1,1,2,2-
Dissolved in tetrachloroethane (20ml) and diluted with diethyl
Add n-hexylphosphonate (0.59) to 145
Heat at ℃ for 1.5 hours.
減圧下、溶媒を留去し、残渣にエーテルを加え放置すれ
ば目的物の結晶(0.45g)を得る。融点205〜2
07℃0IR(KBr,α「り:1760,1725,
1695NMR(DMSO−D6,δ):2.12(3
H,S)3.36実施例 37α−メトキシー7β−フ
エニルアセトアミドー3−メチル−3−セフエム一4−
カルボン酸トリクロルエチルエステルの製法。The solvent was distilled off under reduced pressure, ether was added to the residue, and the mixture was allowed to stand to obtain crystals (0.45 g) of the desired product. Melting point 205~2
07℃0IR (KBr, α'ri: 1760, 1725,
1695NMR (DMSO-D6, δ): 2.12 (3
H,S) 3.36 Example 37α-methoxy7β-phenylacetamide 3-methyl-3-cepheme-4-
Process for producing carboxylic acid trichloroethyl ester.
6α−メトキシ−6β−フエニルアセトアミド一2,2
−ジメチルペナム一3−カルボン酸トリクロルエチルエ
ステル−1−オキサイド(1.09)を1,1,2,2
−テトラクロルエタン(20m0に溶かし、ジエチル−
2−クロルエチルホスホネート(0.59)を加え、1
45℃で2.5時間加熱する。6α-methoxy-6β-phenylacetamide-2,2
-dimethylpenam-3-carboxylic acid trichloroethyl ester-1-oxide (1.09) to 1,1,2,2
-Tetrachloroethane (dissolved in 20m0, diethyl-
Add 2-chloroethylphosphonate (0.59) and add 1
Heat at 45°C for 2.5 hours.
減圧下、溶媒を留去し、残渣をシリカゲルタロマトグラ
フイ一で精製する。ベンゼン(5)と酢酸エチル(1)
の混液で溶出する部分より目的物の結晶(0.429)
を得る。実施例 4
7α−メトキシー7β−フエニルアセトアミド一3−メ
チル−3−セフエム一4−カルボン酸ベンジルエステル
の製法。The solvent was distilled off under reduced pressure, and the residue was purified by silica gel talomatography. Benzene (5) and ethyl acetate (1)
Crystals of the target substance (0.429) were obtained from the part eluted with the mixture of
get. Example 4 Method for producing 7α-methoxy7β-phenylacetamide-13-methyl-3-cephem-4-carboxylic acid benzyl ester.
6α−メトキシ−6β−フエニルアセトアミド一2,2
−ジメチルペナム一3−カルボン酸ベンジルエステル一
1−オキサイド(1.09)を1,1,2,2−テトラ
クロルエタン(20m1)に溶かし、ジエチル−n−ヘ
キシルホスホネート(0.5g)を加え、145℃で1
.5時間加熱する。6α-methoxy-6β-phenylacetamide-2,2
-Dimethylpenam-3-carboxylic acid benzyl ester-1-oxide (1.09) was dissolved in 1,1,2,2-tetrachloroethane (20ml), diethyl-n-hexylphosphonate (0.5g) was added, 1 at 145℃
.. Heat for 5 hours.
冷後、減圧下、溶媒を留去し、残渣をシリカゲルクロマ
トグラフイ一により精製する。ベンゼン(5)と酢酸エ
チル(1)の混液で流出する部分より目的物の結晶(0
.409)を得る。融点181〜182℃o実施例 5
7α−メトキシー7β−フエニルアセトアミドー3−メ
チル−3−セフエム一4−カルボン酸メチルエステルの
製法。After cooling, the solvent is distilled off under reduced pressure, and the residue is purified by silica gel chromatography. Crystals of the target product (0
.. 409). Melting point 181-182℃ o Example 5
A method for producing 7α-methoxy 7β-phenylacetamide 3-methyl-3-cephem-4-carboxylic acid methyl ester.
6α−メトキシ−6β−フエニルアセトアミドー2,2
−ジメチルペナム一3−カルボン酸メチルエステル−1
−オキサイド(0.59)を1,1,2,2−テトラク
ロルエタン(20m1)に溶かし、ジエチル−n−ヘキ
シルホスホネート(0.19)を加え145℃に2時間
加熱する。6α-methoxy-6β-phenylacetamide 2,2
-dimethylpenam-3-carboxylic acid methyl ester-1
-oxide (0.59) was dissolved in 1,1,2,2-tetrachloroethane (20ml), diethyl-n-hexylphosphonate (0.19) was added and heated to 145°C for 2 hours.
減圧下、溶媒を留去し、残渣を酢酸エチルに溶かし、シ
リカゲルカラムクロマトグラフイ一で精製する。ベンゼ
ン(3)と酢酸エチル(1)の混液で流出する部分より
、カルメラ状の目的物0.219を得る。実施例 6
7α−メトキシー7β−フエニルアセトアミド一3−メ
チル−3−セフエム一4−カルボン酸ベンジルエステル
の製法。The solvent was distilled off under reduced pressure, the residue was dissolved in ethyl acetate, and purified by silica gel column chromatography. From the mixed solution of benzene (3) and ethyl acetate (1) flowing out, 0.219 of the target product in the form of carmela is obtained. Example 6 Method for producing 7α-methoxy7β-phenylacetamide-13-methyl-3-cephem-4-carboxylic acid benzyl ester.
6α−メトキシ−6β−フエニルアセトアミド2,2−
ジメチルペナム一3−カルボン酸ベンジルエステル一1
−オキサイド1.09をブロムベンゼン(20m1)に
溶かし、ジエチル−。6α-methoxy-6β-phenylacetamide 2,2-
Dimethylpenam-3-carboxylic acid benzyl ester-1
-Dissolve 1.09% of the oxide in bromobenzene (20ml) and add diethyl.
−ヘキシルホスホネート(0.59)を加え146℃で
1.5時間加熱する。冷後、減圧下、溶媒を留去し、残
渣をシリカゲルカラムクロマトグラフイ一により精製す
る。ベンゼン(5)と酢酸エチル(1)の混液で流出す
る部分より実施例4と同じ目的物の結晶(0.399)
を得る。実施例 7
7α−メトキシー7β−フエニルアセトアミド3−メチ
ル−3−セフエム一4−カルボン酸ベンジルエステルの
製法。-Hexylphosphonate (0.59) is added and heated at 146°C for 1.5 hours. After cooling, the solvent is distilled off under reduced pressure, and the residue is purified by silica gel column chromatography. Crystals of the same target product as in Example 4 (0.399) were obtained from the outflowing portion of the mixed solution of benzene (5) and ethyl acetate (1).
get. Example 7 Method for producing 7α-methoxy 7β-phenylacetamide 3-methyl-3-cephem-4-carboxylic acid benzyl ester.
6α−メトキシ−6β−フエニルアセトアミド2,2−
ジメチルペナム一3−カルボン酸ベンジルエステル−1
−オキサイド(1.0g)をmクロルトルエン(20m
1)に溶かし、ジエチル−n−ヘキシルホスホネート(
0.59)を加え、油浴上1.5時間加熱還流する。6α-methoxy-6β-phenylacetamide 2,2-
Dimethylpenam-3-carboxylic acid benzyl ester-1
- oxide (1.0g) mchlorotoluene (20m
1) and diethyl-n-hexylphosphonate (
0.59) and heated under reflux on an oil bath for 1.5 hours.
冷後、減圧下、溶媒を留去し、残渣をシリカゲルタロマ
トグラフイ一により精製する。ベンゼン(5)と酢酸エ
チル(1)の混液で流出する部分より実施例4と同じ目
的物の結晶(0.399)を得る。実施例 8
7α−メトキシー7β一(2−チエニルアセトアミド)
−3−アセトキシメチル−3−セフエム一4−カルボン
酸ベンツヒドリルエステルの製法。After cooling, the solvent is distilled off under reduced pressure, and the residue is purified by silica gel talomatography. Crystals (0.399) of the same target product as in Example 4 are obtained from the mixed solution of benzene (5) and ethyl acetate (1) flowing out. Example 8 7α-methoxy 7β-(2-thienylacetamide)
-Production method of 3-acetoxymethyl-3-cephem-4-carboxylic acid benzhydryl ester.
6α−メトキシ−6β−(2−チエニルアセトアミド)
−2−メチル−2−アセトキシメチルペナム一3−カル
ボン酸ベンズヒドリルエステル一1一オキサイド(1.
09)を1,1,2,2−テトラクロルエタン(20m
1)に溶かし、ジエチルn−ヘキシルホスホネート(0
.29)を加え、145℃で1.5時間加熱する。6α-methoxy-6β-(2-thienylacetamide)
-2-Methyl-2-acetoxymethylpenam-3-carboxylic acid benzhydryl ester-11-oxide (1.
09) in 1,1,2,2-tetrachloroethane (20 m
1) and diethyl n-hexylphosphonate (0
.. Add 29) and heat at 145°C for 1.5 hours.
冷後、減圧下、溶媒を留去し、残渣をシリカゲルクロマ
トグラフイ一により精製する。ベンゼン(5)と酢酸エ
チル(1)の混液で流出する部分より目的物の結晶(0
.399)を得る。R(αV):1780,1740,
1690NMR(CDCl3,δ):2.00(3H,
S)336(2H)3.49(3H,S)3.89(2
H,S)4.96(2H)5.08(1H,S)6.8
〜7.4(13H,M)実施例 9
7α−メトキシー7β−フエニルアセトアミド3−カル
バモイルオキシメチル−3−セフエム一4−カルボン酸
ベンズヒドリルエステルの製法。After cooling, the solvent is distilled off under reduced pressure, and the residue is purified by silica gel chromatography. Crystals of the target product (0
.. 399) is obtained. R(αV): 1780, 1740,
1690NMR (CDCl3, δ): 2.00 (3H,
S) 336 (2H) 3.49 (3H, S) 3.89 (2
H, S) 4.96 (2H) 5.08 (1H, S) 6.8
~7.4 (13H,M) Example 9 Method for producing 7α-methoxy7β-phenylacetamide 3-carbamoyloxymethyl-3-cephem-4-carboxylic acid benzhydryl ester.
6α−メトキシ−6β−アセトアミド−2−メチル−2
−カルバモイルオキシメチルペナム一3−カルボン酸ベ
ンズヒドリルエステル一1−オキサイド(1.09)を
1,1,2,2−テトラタロルエタン(20m1)に溶
かし、ジエチル−n−ヘキシルホスホネート(0.29
)を加え、145℃で1.5時間加熱する。6α-methoxy-6β-acetamido-2-methyl-2
-Carbamoyloxymethylpenam-3-carboxylic acid benzhydryl ester-1-oxide (1.09) was dissolved in 1,1,2,2-tetrathalolethane (20ml) and diethyl-n-hexylphosphonate (0 .29
) and heat at 145°C for 1.5 hours.
冷後、減圧下、溶媒を留去し、残渣をシリカゲルクロマ
トグラフイ一により精製する。ベンゼン(3)と酢酸エ
チル(1)の混液で流出する部分よりガラス状の目的物
(0.329)を得る。1R(CHCl3,(T1):
1780,1730,1680NMR(CDCl3,δ
):3.30(2H,br)3.40(3H,S)3.
60(2H,S)4.7〜5.0(4H,M)5.0(
1H,S)6.85(1H,S)7,0〜7.5(15
H,M)参考例 1
6α−メトキシ−6β−フエニルアセトアミド2,2−
ジメチルペナム一3−カルボン酸トリクロルエチルエス
テル−1−オキサイドを米国化学会誌95巻 2401
頁(1973年)の方法に準じて、6β−フエニルアセ
トアミド一2,2ジメチルペナム一3−カルボン酸トリ
クロルエチルエステル−1−オキサイドより合成した。After cooling, the solvent is distilled off under reduced pressure, and the residue is purified by silica gel chromatography. A glassy target product (0.329) was obtained from the outflowing portion of a mixed solution of benzene (3) and ethyl acetate (1). 1R(CHCl3, (T1):
1780, 1730, 1680NMR (CDCl3, δ
): 3.30 (2H, br) 3.40 (3H, S) 3.
60 (2H, S) 4.7-5.0 (4H, M) 5.0 (
1H, S) 6.85 (1H, S) 7,0 to 7.5 (15
H, M) Reference example 1 6α-methoxy-6β-phenylacetamide 2,2-
Dimethylpenam-3-carboxylic acid trichloroethyl ester-1-oxide, Journal of the American Chemical Society, Vol. 95, 2401
(1973) from 6β-phenylacetamide-2,2-dimethylpenam-3-carboxylic acid trichloroethyl ester-1-oxide.
融 点147〜148℃。Melt Point 147-148°C.
IR(KBr,a「り :1795,1765,167
0NMR(CDCl3,δ):1,30(3H,S)1
.72(3H,S)3.39(3H,S)3.68(2
H,S)4.67(1H,d,J−12HZ)4,74
(1H,S)5.01(1H,S).5.02(1H,
d,J=12HZ)7.32(5H,S)参考例 2
参考例1と同様にして次の化合物を得た。IR (KBr, a'ri: 1795, 1765, 167
0NMR(CDCl3,δ):1,30(3H,S)1
.. 72 (3H, S) 3.39 (3H, S) 3.68 (2
H, S) 4.67 (1H, d, J-12HZ) 4,74
(1H,S)5.01(1H,S). 5.02 (1H,
d, J=12HZ)7.32(5H,S) Reference Example 2 The following compound was obtained in the same manner as in Reference Example 1.
6α−メトキシ−6β−フエニルアセトアミド2,2−
ジメチルペナム一3−カルボン酸ベンジルエステル一1
−オキサイド 融点74〜77℃。6α-methoxy-6β-phenylacetamide 2,2-
Dimethylpenam-3-carboxylic acid benzyl ester-1
-Oxide Melting point 74-77°C.
IR(KBr,ml):1795
NMR(CDCl3,δ):1,06(3H,S)15
9(3H,S)338(3H,S)366(2H,S)
4.60(1H,S)4.94(1H,S)5.15(
1H,d,J=12HZ)5.32(1H,d,J=1
2HZ)7,2〜7.5(10H,M)6α−メトキシ
−6β−フエニルアセトアミド2,2−ジメチルペナム
一3−カルボン酸メチルエステル−1−オキサイド。IR (KBr, ml): 1795 NMR (CDCl3, δ): 1,06 (3H, S) 15
9 (3H, S) 338 (3H, S) 366 (2H, S)
4.60 (1H, S) 4.94 (1H, S) 5.15 (
1H, d, J = 12HZ) 5.32 (1H, d, J = 1
2HZ) 7,2-7.5 (10H,M) 6α-methoxy-6β-phenylacetamide 2,2-dimethylpenam-3-carboxylic acid methyl ester-1-oxide.
Claims (1)
セチル基を、R_2は水素原子、アセトキシ基またはカ
ルバモイルオキシ基を、R_3、R_4、およびR_5
は同一または異なつて水素原子、フェニル基またはトリ
ハロゲノメチル基をそれぞれ意味する。 )で表わされるペニシリン誘導体を触媒の存在下、溶媒
中で加熱することによる一般式▲数式、化学式、表等が
あります▼ (式中、R_1、R_2、R_3、R_4およびR_5
は前掲と同じものを意味する。 )で表わされるセフアロスポリン誘導体の製法において
触媒として、一般式▲数式、化学式、表等があります▼ (式中、Rは低級アルキル基を、Yは水素原子またはハ
ロゲン原子を、nは1〜7の整数を意味する。 )で表わされるリン化合物を用いることを特徴とする方
法。 2 一般式 ▲数式、化学式、表等があります▼ (式中、R_1はフェニルアセチル基またはチエニルア
セチル基を、R_2は水素原子、アセトキシ基またはカ
ルバモイルオキシ基、R_3、R_4およびR_5は同
一または異なつて水素原子、フェニル基またはトリハロ
ゲノメチル基をそれぞれ意味する。 )で表わされるペニシリン誘導体を触媒の存在下、溶媒
中で加熱することによる一般式▲数式、化学式、表等が
あります▼ (式中、R_1、R_2、R_3、R_4およびR_5
は前掲と同じものを意味する。 )で表わされるセフアロスポリン誘導体の製法において
、触媒として一般式▲数式、化学式、表等があります▼ (式中、Rは低級アルキル基を、Yは水素原子またはハ
ロゲン原子を、nは1〜7の整数を意味する。 )で表わされるリン化合物を用い、溶媒として沸点10
0℃以上の有機ハロゲン化合物を用いることを特徴とす
る方法。[Claims] 1 General formula ▲ Numerical formulas, chemical formulas, tables, etc. ▼ , and R_5
are the same or different and each means a hydrogen atom, a phenyl group or a trihalogenomethyl group. ) by heating the penicillin derivative represented by the formula in a solvent in the presence of a catalyst ▲ There are mathematical formulas, chemical formulas, tables, etc.
means the same as above. ) In the method for producing cephalosporin derivatives, the catalyst is represented by the general formula ▲mathematical formula, chemical formula, table, etc. means an integer.) A method characterized by using a phosphorus compound represented by: 2 General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R_1 is a phenylacetyl group or thienylacetyl group, R_2 is a hydrogen atom, acetoxy group or carbamoyloxy group, and R_3, R_4 and R_5 are the same or different. A general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (in the formula, R_1, R_2, R_3, R_4 and R_5
means the same as above. ) In the method for producing cephalosporin derivatives represented by the general formula ▲mathematical formula, chemical formula, table, etc. as a catalyst▼ (in the formula, R is a lower alkyl group, Y is a hydrogen atom or a halogen atom, and n is an atom of 1 to 7). ) is used as a solvent, and the boiling point is 10.
A method characterized by using an organic halogen compound having a temperature of 0°C or higher.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49135292A JPS5943476B2 (en) | 1974-11-22 | 1974-11-22 | Method for producing cephalosporin derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49135292A JPS5943476B2 (en) | 1974-11-22 | 1974-11-22 | Method for producing cephalosporin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5163189A JPS5163189A (en) | 1976-06-01 |
| JPS5943476B2 true JPS5943476B2 (en) | 1984-10-22 |
Family
ID=15148277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49135292A Expired JPS5943476B2 (en) | 1974-11-22 | 1974-11-22 | Method for producing cephalosporin derivatives |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5943476B2 (en) |
-
1974
- 1974-11-22 JP JP49135292A patent/JPS5943476B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5163189A (en) | 1976-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5813535B2 (en) | Production method of acyldiamine | |
| JPS61215399A (en) | Phosphonate group-containing herbicide and manufacture of intermediate from benzoxazine | |
| JPH0148911B2 (en) | ||
| US3227721A (en) | Process for preparing 2-methyl-3-hydroxypyridines | |
| JPS5922711B2 (en) | Method for producing benzoxazolinone derivatives | |
| US5264443A (en) | 3-aryl oxazolidinone compounds and therapeutic use thereof | |
| US3778450A (en) | Certain bicyclic lactones | |
| JPS5943476B2 (en) | Method for producing cephalosporin derivatives | |
| JPH01224364A (en) | Production of herbicidal o-carboxyarylimidazolinones | |
| JPS5943477B2 (en) | Method for producing cephalosporins | |
| JPS647072B2 (en) | ||
| CN109485661A (en) | The method [3+2] cycloaddition synthesis benzothiazole and dislike azole compounds | |
| JP2986003B2 (en) | 2-Alkyl-3-styryloxiranecarboxylic acid ester and method for producing the same | |
| JPH02149546A (en) | Preparation of naphthalene derivative | |
| JPH0977751A (en) | Process for producing N-unsubstituted isoxazolidine | |
| US4182892A (en) | Malonic esters | |
| JP2535999B2 (en) | Method for the benzylideneation of the α-position of acetonyl phosphonates | |
| JPH0247470B2 (en) | INDOMETASHINJUDOTAI | |
| JP3655311B2 (en) | Method for producing phthalide compound | |
| KR810001090B1 (en) | Method for preparing 1-azaxanthone-3-carboxylic acid derivative | |
| JPS61180751A (en) | Beta-(acetylamino)acrylic ester | |
| JPH0597735A (en) | Production of optically active secondary alcohol | |
| JPH02172986A (en) | Method for producing 3-hydroxy-2-thiophenecarboxylic acid derivative | |
| JPS6117590A (en) | Manufacture of cephalosporin compound | |
| JPH02286669A (en) | Production of thiazole carboxylic acid chlorides |